← Back to Search

Procedure

Coolsculpting With Cooltone Verses Coolsculpting Alone for the Banana Roll Area

N/A
Waitlist Available
Research Sponsored by Goldman, Butterwick, Fitzpatrick and Groff
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 18 weeks
Awards & highlights
No Placebo-Only Group

Summary

to evaluate the benefit and efficacy of CoolSculpting Elite study treatments versus CoolSculpting Elite study treatments followed by a series CoolTone for underneath the buttocks (also known as the banana roll).

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~18 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 18 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Improvement in Appearance of the Banana Roll Region Based on Clinical Photographs
appearance of the banana roll region based on Investigator Global Aesthetic Improvement Scales
Secondary study objectives
Patient Treatment Satisfaction Survey
Subject Global Aesthetic Improvement Scale

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: GROUP A=CoolSculpting Elite and CoolToneExperimental Treatment1 Intervention
Group A: Study subjects will have a total of 1 or 2 bilateral CoolSculpting Elite sessions to the banana roll area 6 weeks prior to four EMMS treatment sessions during the study.
Group II: GROUP B CoolSculpting Elite aloneActive Control1 Intervention
Group B: Study subjects will have a total of 1 or 2 bilateral CoolSculpting Elite sessions to the banana roll area.

Find a Location

Who is running the clinical trial?

Goldman, Butterwick, Fitzpatrick and GroffLead Sponsor
31 Previous Clinical Trials
649 Total Patients Enrolled
~4 spots leftby Dec 2025